Design and Feasibility of a Study Using the Clinical Practice Research Datalink General Practice OnLine Database (CPRD GOLD) To Assess the Risk of New Onset of Auto-Immune Diseases (NOAD) Following Administration of the Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine

Manel Pladevall-Vila; D Rosillon; C Willame; Manel Pladevall-Vila; J Zima; JH van den Bosch; E Bunge; T van Staa; R Boggon; L Baril

Design and Feasibility of a Study Using the Clinical Practice Research Datalink General Practice OnLine Database (CPRD GOLD) To Assess the Risk of New Onset of Auto-Immune Diseases (NOAD) Following Administration of the Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine

Rosillon, D., Willame, C., Pladevall-Vila, M., Zima, J., van den Bosch, JH., Bunge, E., van Staa, T., Boggon, R., & Baril, L. (2014). Design and Feasibility of a Study Using the Clinical Practice Research Datalink General Practice OnLine Database (CPRD GOLD) To Assess the Risk of New Onset of Auto-Immune Diseases (NOAD) Following Administration of the Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine. Pharmacoepidemiology and Drug Safety, 23(Suppl. 1), 164-165.

Copy citation